News and Insights from the world of BranchLab.
RFK Jr. has consistently advocated for a ban on pharmaceutical advertising, as evidenced by his discussions on prominent platforms like The Joe Rogan Experience and his social media posts, including…
Does the incoming Trump administration and RFK Jr.’s potential appointment as the head of Health and Human Services (HHS) spell the end of TV drug ads? Probably not, argues Josh Walsh, CEO…
President-elect Donald Trump named Robert F. Kennedy Jr. as his pick to run the Department of Health and Human Services (HHS) when he returns to the White House. Kennedy has…
As the landscape of healthcare advertising evolves, how can brands effectively reach their audiences while ensuring data privacy? Fierce Pharma’s Michelle Benz sought to find the answer to this pressing…
August 19, 2024 – New York, NY: BranchLab has appointed Errol Taylor to its Board of Advisors to help guide the newly launched company on its mission to reimagine healthcare…
As a part of the MediaPost webinar series, we joined a session hosted by Causal IQ to discuss Healthcare Professionals (HCPs) and how to best reach & market to them…
In Partnership with BranchLab, Causal IQ Introduces a Revolutionary Privacy-Focused Approach to Healthcare Advertising July 18, 2024 – LOS ANGELES – Causal IQ, a leading provider of advanced digital advertising…
Amid increased state and industry regulations, BranchLab provides a new solution for healthcare and pharma brands to reach consumers in a privacy-compliant way June 6, 2024 – New York, NY…